Cargando…

Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands

INTRODUCTION: To improve therapeutic decision making, it is crucial that information regarding adverse drug reactions reaches patients. It is not enough to disseminate such findings through regulatory and scientific channels; targeted efforts to reach patients are necessary. One possible avenue is t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Härmark, Linda, Weits, Gerda, Meijer, Rietje, Santoro, Federica, Norén, G. Niklas, van Hunsel, Florence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395903/ https://www.ncbi.nlm.nih.gov/pubmed/32418193 http://dx.doi.org/10.1007/s40264-020-00932-5

Ejemplares similares

Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands
por: Härmark, Linda, et al.
Publicado: (2020)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Adverse Drug Reactions of Intranasal Corticosteroids in the Netherlands: An Analysis from the Netherlands Pharmacovigilance Center
por: Rollema, Corine, et al.
Publicado: (2022)

COVID-19 vaccine reactogenicity – A cohort event monitoring study in the Netherlands using patient reported outcomes
por: Rolfes, Leàn, et al.
Publicado: (2022)

The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands
por: Rolfes, Leàn, et al.
Publicado: (2016)

Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands
por: Glerum, Pieter J., et al.
Publicado: (2020)

A prediction model‐based algorithm for computer‐assisted database screening of adverse drug reactions in the Netherlands
por: Scholl, Joep H.G., et al.
Publicado: (2017)

Adverse drug reactions of montelukast in children and adults
por: Haarman, Meindina G., et al.
Publicado: (2017)

Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature
por: Sartori, Daniele, et al.
Publicado: (2022)

Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK
por: de Vries, Sieta T., et al.
Publicado: (2021)

Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports
por: Ekhart, Corine, et al.
Publicado: (2022)

Desogestrel and panic attacks – a new suspected adverse drug reaction reported by patients and health care professionals on spontaneous reports
por: Watson, Sarah, et al.
Publicado: (2018)

Factors Contributing to Best Practices for Patient Involvement in Pharmacovigilance in Europe: A Stakeholder Analysis
por: van Hoof, Monica, et al.
Publicado: (2022)

Patient preferences and expectation for feedback on adverse drug reaction reports submitted in Ghana
por: Sabblah, George Tsey, et al.
Publicado: (2019)

Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands
por: van der Boor, Saskia C., et al.
Publicado: (2023)

Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre
por: Watson, Sarah, et al.
Publicado: (2017)

The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis
por: Rolfes, Leàn, et al.
Publicado: (2017)

Red yeast rice (Monascus purpureus) supplements: Case series assessment of spontaneously reported cases to The Netherlands Pharmacovigilance Centre Lareb
por: Vrolijk, Misha F., et al.
Publicado: (2020)

Pharmacovigilance Data as a Trigger to Identify Antimicrobial Resistance and Inappropriate Use of Antibiotics: A Study Using Reports from The Netherlands Pharmacovigilance Centre
por: Habarugira, Jean Marie Vianney, et al.
Publicado: (2021)

Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center
por: DAVIDSON, Linda, et al.
Publicado: (2022)

Time to onset in statistical signal detection revisited: A follow‐up study in long‐term onset adverse drug reactions
por: Scholl, Joep H.G., et al.
Publicado: (2019)

Authors’ Reply to Mungmunpuntipantip et al.’s Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
por: Kant, Agnes, et al.
Publicado: (2022)

Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase
por: Sandberg, Lovisa, et al.
Publicado: (2020)

Characteristics, Quality and Contribution to Signal Detection of Spontaneous Reports of Adverse Drug Reactions Via the WEB-RADR Mobile Application: A Descriptive Cross-Sectional Study
por: Oosterhuis, Ingrid, et al.
Publicado: (2018)

Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands
por: Kant, Agnes, et al.
Publicado: (2022)

Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting
por: Iwasa, Eiko, et al.
Publicado: (2020)

Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands
por: Dittrich, Anne T. M., et al.
Publicado: (2020)

Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study
por: de Heus, Roel, et al.
Publicado: (2009)

Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study
por: de Vries, Sieta T., et al.
Publicado: (2019)

Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose
por: Raethke, Monika, et al.
Publicado: (2023)

Health-care costing in the Netherlands
por: Meijer, R, et al.
Publicado: (2010)

Red-Brown Urine Discolouration in Two Patients Taking Mesalamine
por: Smeets, Tim, et al.
Publicado: (2016)

Curling of Hair in Two Female Patients Taking Alitretinoin
por: Alting, Kim, et al.
Publicado: (2018)

The prevalence of adverse postnatal outcomes for mother and infant in the Netherlands
por: de Groot, Nynke, et al.
Publicado: (2018)

Clustering of homicide with other adverse health outcomes in the Netherlands
por: van Breen, J.A., et al.
Publicado: (2022)

Adversity, emotion, and resilience among Syrian refugees in the Netherlands
por: Fadhlia, Tengku Nila, et al.
Publicado: (2022)

Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature
por: Duijster, Janneke W., et al.
Publicado: (2023)

Adverse Transfusion Reactions in Critically Ill Patients
por: Tomasella, Federica, et al.
Publicado: (2014)

Adverse reactions
Publicado: (1985)

Canine Staphylococcus argenteus: Case Report from The Netherlands
por: Meijer, Eelco F. J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8q2h07drg41b6t6tdo8rooenlq